JohnJosephShelmetMD

Endocrinology • Lawrence, NJ

Diabetes, Lipid Metabolism

Practice limited to diabetes

Join to view full profile

Dr. Shelmet is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Shelmet's full profile

Already have an account?

Office
3131 Princeton Pike
Bldg 2B, Suite 104
Lawrence, NJ 08648
Phone+1 609-896-8050

Fax+1 609-896-3053
Is this information wrong?

Education & Training

Temple University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1984 - 1987
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 1981 - 1984
Rutgers Health/Robert Wood Johnson Medical SchoolInternship, Internal Medicine, 1981 - 1982
UMDNJ - Rutgers Medical SchoolMD, Medicine, 1977 - 1981
Rutgers Robert Wood Johnson Medical SchoolClass of 1981
Rider UniversityBA, Biochemistry, 1973 - 1977

Certifications & Licensure

NJ State Medical License 1983 - 2025
PA State Medical License 1984 - 1990
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2023
Top Doctors: New York Metro Area Castle Connolly, 2007-2023
Fellow (FACE) American Association of Clinical Endocrinology

Publications & Presentations

PubMed

67 citations
A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge x 6 mm needle versu...
Sherwyn Schwartz, David R. Hassman, John Shelmet, Richard Sievers, Richard Weinstein, John Liang, William Lyness> ;Clinical Therapeutics. 2004 Oct 1
7 citations
Patient perception and use of an insulin injector/glucose monitor combined device.
Bruce W. Bode, John Shelmet, Brent Gooch, David R. Hassman, John Liang, Jorgen K. Smedegaard, Soren E. Skovlund, Birgitte Berg, William Lyness, Stephen H. Schneider> ;The Diabetes Educator. 2004 Mar 1
48 citations
Preference and resource utilization in elderly patients: InnoLet versus vial/syringe.
John Shelmet, Sherwyn Schwartz, John Cappleman, Gregory M. Peterson, Soren E. Skovlund, Lene Lytzen, L Nicklasson, John Liang, William Lyness> ;Diabetes Research and Clinical Practice. 2004 Jan 1
The management of non-insulin-dependent diabetes mellitus.
Krosnick, A., Shelmet, J. J.> ;Clin Ther. 1988
13 citations
Nonbinding inhibitory antiinsulin receptor antibodies. A new type of autoantibodies in human diabetes.
G. Boden, Yoko Fujita-Yamaguchi, R. Shimoyama, John J. Shelmet, Luc Tappy, I Rezvani, O E Owen> ;The Journal of Clinical Investigation. 1988 Jun 1
158 citations
Ethanol causes acute inhibition of carbohydrate, fat, and protein oxidation and insulin resistance.
John J. Shelmet, George A. Reichard, Charles L. Skutches, Robert D. Hoeldtke, Oliver E. Owen, Guenther Boden> ;The Journal of Clinical Investigation. 1988 Apr 1
Treat human diabetes with human insulin.
Shelmet, J. J.> ;N J Med. 1987 Oct
86 citations
Treatment of Inoperable Glucagonoma with the Long-Acting Somatostatin Analogue SMS 201–995
Guenther Boden, Isabel G. Ryan, Brenda L. Eisenschmid, John J. Shelmet, Oliver E. Owen> ;The New England Journal of Medicine. 1986 Jun 26
Effects of anti-insulin receptor antibodies (AIRA) on downregulation and turnover of insulin receptors on cultured hepatocytes.
Shimoyama, R., Shelmet, J. J., Savage, C. R. Jr, Boden, G.> ;Diabetes. 1986 Jan
Join now to see all

Hospital Affiliations

Penn Medicine Princeton Medical CenterPlainsboro, New Jersey

External Links

JJSDiabeteshttp://jjsdiabetes.blogspot.com/